Open AccessPrenatal Administration of Betamethasone and Neonatal Respiratory Distress Syndrome in Multifetal Pregnancies: A Randomized Controlled Trial
Author(s) -
Fatemeh Abbasalizadeh,
Khadijeh Pouya,
Raana Zakeri,
Rana Asgari-Arbat,
Shamsi Abbasalizadeh,
Neda Parnianfard
Publication year - 2020
Publication title -
current clinical pharmacology
Language(s) - English
Resource type - Journals
eISSN - 2212-3938
pISSN - 1574-8847
DOI - 10.2174/1574884714666191007154936
Subject(s) - betamethasone , medicine , neonatal respiratory distress syndrome , randomized controlled trial , respiratory distress , gestational age , obstetrics , incidence (geometry) , gestation , birth weight , apgar score , pregnancy , pediatrics , anesthesia , biology , genetics , physics , optics
Neonatal Respiratory Distress Syndrome (NRDS) is one of the most frequent causes of neonatal mortality especially in premature infants. Although it has been well established that maternal antenatal corticosteroid therapy has a positive effect on NRDS reduction, yet the effectiveness of this treatment in multifetal pregnancies is dubious.